{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:41:48Z","timestamp":1790797308750,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-IDR-110-01"],"award-info":[{"award-number":["AS-IDR-110-01"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-GC-110-MD01"],"award-info":[{"award-number":["AS-GC-110-MD01"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-BRPT-110-02"],"award-info":[{"award-number":["AS-BRPT-110-02"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-IA-109-L02"],"award-info":[{"award-number":["AS-IA-109-L02"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020363","name":"Institute for Information Industry, Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2321-B-001-015"],"award-info":[{"award-number":["MOST 107-2321-B-001-015"]}],"id":[{"id":"10.13039\/501100020363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["VTA110-V5-5-1"],"award-info":[{"award-number":["VTA110-V5-5-1"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus-induced disease 19 (COVID-19) infects more than three hundred and sixty million patients worldwide, and people with severe symptoms frequently die of acute respiratory distress syndrome (ARDS). Recent studies indicated that excessive neutrophil extracellular traps (NETs) contributed to immunothrombosis, thereby leading to extensive intravascular coagulopathy and multiple organ dysfunction. Thus, understanding the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced NET formation would be helpful to reduce thrombosis and prevent ARDS in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We incubated SARS-CoV-2 with neutrophils in the presence or absence of platelets to observe NET formation. We further isolated extracellular vesicles from COVID-19 patients' sera (COVID-19-EVs) to examine their ability to induce NET formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We demonstrated that antagonistic mAbs against anti-CLEC5A mAb and anti-TLR2 mAb can inhibit COVID-19-EVs-induced NET formation, and generated\n                      <jats:italic>clec5a<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      <jats:italic>\/tlr2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mice to confirm the critical roles of CLEC5A and TLR2 in SARS-CoV-2-induced lung inflammation in vivo. We found that virus-free extracellular COVID-19 EVs induced robust NET formation via Syk-coupled C-type lectin member 5A (CLEC5A) and TLR2. Blockade of CLEC5A inhibited COVID-19 EVs-induced NETosis, and simultaneous blockade of CLEC5A and TLR2 further suppressed SARS-CoV-2-induced NETosis in vitro. Moreover, thromboinflammation was attenuated dramatically in\n                      <jats:italic>clec5a<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      <jats:italic>\/tlr2<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that SARS-CoV-2-activated platelets produce EVs to enhance thromboinflammation via CLEC5A and TLR2, and highlight the importance of CLEC5A and TLR2 as therapeutic targets to reduce the risk of ARDS in COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-022-00832-z","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T14:03:06Z","timestamp":1657634586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation"],"prefix":"10.1186","volume":"29","author":[{"given":"Pei-Shan","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hwa","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9415-346X","authenticated-orcid":false,"given":"Shie-Liang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"832_CR1","unstructured":"https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it."},{"issue":"8","key":"832_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","journal-title":"N Engl J Med"},{"issue":"10223","key":"832_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"10229","key":"832_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"832_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u20137.","journal-title":"Thromb Res"},{"issue":"20","key":"832_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020;382(20): e60.","journal-title":"N Engl J Med"},{"key":"832_CR7","doi-asserted-by":"crossref","unstructured":"Wichmann D, et al. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. 2020.","DOI":"10.7326\/L20-1206"},{"key":"832_CR8","doi-asserted-by":"crossref","unstructured":"Lax SF, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020.","DOI":"10.2139\/ssrn.3586685"},{"issue":"3","key":"832_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","volume":"18","author":"SX Gu","year":"2021","unstructured":"Gu SX, et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. 2021;18(3):194\u2013209.","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"832_CR10","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","volume":"123","author":"K Martinod","year":"2014","unstructured":"Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123(18):2768\u201376.","journal-title":"Blood"},{"issue":"2","key":"832_CR11","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/ATVBAHA.120.315267","volume":"41","author":"H Ng","year":"2021","unstructured":"Ng H, et al. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19. Arterioscler Thromb Vasc Biol. 2021;41(2):988\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"832_CR12","doi-asserted-by":"crossref","unstructured":"Barnes BJ, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020; 217(6).","DOI":"10.1084\/jem.20200652"},{"issue":"1","key":"832_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13613-021-00899-1","volume":"11","author":"N Yatim","year":"2021","unstructured":"Yatim N, et al. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):113.","journal-title":"Ann Intensive Care"},{"key":"832_CR14","doi-asserted-by":"crossref","unstructured":"Zaid Y, et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020.","DOI":"10.1101\/2020.06.23.20137596"},{"issue":"10","key":"832_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton EA, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169\u201379.","journal-title":"Blood"},{"issue":"5","key":"832_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319\u201329.","journal-title":"Nat Rev Immunol"},{"key":"832_CR17","doi-asserted-by":"crossref","unstructured":"Bautista-Becerril B, et al. Immunothrombosis in COVID-19: implications of neutrophil extracellular traps. Biomolecules. 2021; 11(5).","DOI":"10.3390\/biom11050694"},{"issue":"1","key":"832_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120.","journal-title":"J Hematol Oncol"},{"key":"832_CR19","doi-asserted-by":"crossref","unstructured":"Cappellano G, et al. Circulating platelet-derived extracellular vesicles are a hallmark of sars-cov-2 infection. Cells. 2021; 10(1).","DOI":"10.3390\/cells10010085"},{"key":"832_CR20","doi-asserted-by":"crossref","unstructured":"Zuo Y, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020.","DOI":"10.1172\/jci.insight.138999"},{"issue":"7195","key":"832_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nature07013","volume":"453","author":"ST Chen","year":"2008","unstructured":"Chen ST, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature. 2008;453(7195):672\u20136.","journal-title":"Nature"},{"issue":"1","key":"832_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1182\/blood-2012-05-430090","volume":"121","author":"MF Wu","year":"2013","unstructured":"Wu MF, et al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood. 2013;121(1):95\u2013106.","journal-title":"Blood"},{"issue":"9","key":"832_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00109-016-1409-0","volume":"94","author":"YL Huang","year":"2016","unstructured":"Huang YL, et al. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis. J Mol Med (Berl). 2016;94(9):1025\u201337.","journal-title":"J Mol Med (Berl)"},{"key":"832_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-981-15-1580-4_3","volume":"1204","author":"PS Sung","year":"2020","unstructured":"Sung PS, Chang WC, Hsieh SL. CLEC5A: a promiscuous pattern recognition receptor to microbes and beyond. Adv Exp Med Biol. 2020;1204:57\u201373.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"832_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41467-017-00356-3","volume":"8","author":"ST Chen","year":"2017","unstructured":"Chen ST, et al. CLEC5A is a critical receptor in innate immunity against Listeria infection. Nat Commun. 2017;8(1):299.","journal-title":"Nat Commun"},{"issue":"1","key":"832_CR26","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1038\/s41467-019-10360-4","volume":"10","author":"PS Sung","year":"2019","unstructured":"Sung PS, Huang TF, Hsieh SL. Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A\/TLR2. Nat Commun. 2019;10(1):2402.","journal-title":"Nat Commun"},{"key":"832_CR27","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3389\/fimmu.2019.02867","volume":"10","author":"PS Sung","year":"2019","unstructured":"Sung PS, Hsieh SL. CLEC2 and CLEC5A: pathogenic host factors in acute viral infections. Front Immunol. 2019;10:2867.","journal-title":"Front Immunol"},{"issue":"2","key":"832_CR28","doi-asserted-by":"publisher","DOI":"10.4110\/in.2021.21.e16","volume":"21","author":"YJ Youn","year":"2021","unstructured":"Youn YJ, et al. Nucleocapsid and spike proteins of SARS-CoV-2 drive neutrophil extracellular trap formation. Immune Netw. 2021;21(2): e16.","journal-title":"Immune Netw"},{"issue":"7","key":"832_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng M, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22(7):829\u201338.","journal-title":"Nat Immunol"},{"key":"832_CR30","doi-asserted-by":"crossref","unstructured":"Khan S, et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway. bioRxiv. 2021.","DOI":"10.1101\/2021.03.16.435700"},{"issue":"9","key":"832_CR31","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","volume":"85","author":"I Glowacka","year":"2011","unstructured":"Glowacka I, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122\u201334.","journal-title":"J Virol"},{"issue":"8","key":"832_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009758","volume":"17","author":"CP Sun","year":"2021","unstructured":"Sun CP, et al. Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19. PLoS Pathog. 2021;17(8): e1009758.","journal-title":"PLoS Pathog"},{"issue":"4","key":"832_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2144\/000112729","volume":"44","author":"RH Hubner","year":"2008","unstructured":"Hubner RH, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44(4):507\u201311, 514\u20137.","journal-title":"Biotechniques"},{"issue":"8","key":"832_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807\u201315.","journal-title":"Lancet Respir Med"},{"issue":"7648","key":"832_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","volume":"544","author":"E Lefrancais","year":"2017","unstructured":"Lefrancais E, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544(7648):105\u20139.","journal-title":"Nature"},{"issue":"2","key":"832_CR36","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/ATVBAHA.120.315547","volume":"41","author":"A Rosell","year":"2021","unstructured":"Rosell A, et al. Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report. Arterioscler Thromb Vasc Biol. 2021;41(2):878\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"832_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104422","volume":"85","author":"M Hassanpour","year":"2020","unstructured":"Hassanpour M, et al. The role of extracellular vesicles in COVID-19 virus infection. Infect Genet Evol. 2020;85: 104422.","journal-title":"Infect Genet Evol"},{"issue":"6","key":"832_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/infdis\/jiaa789","volume":"223","author":"JR Strich","year":"2021","unstructured":"Strich JR, et al. Fostamatinib inhibits neutrophils extracellular traps induced by COVID-19 patient plasma: a potential therapeutic. J Infect Dis. 2021;223(6):981\u20134.","journal-title":"J Infect Dis"},{"issue":"15","key":"832_CR39","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","volume":"120","author":"JM Burkhart","year":"2012","unstructured":"Burkhart JM, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-82.","journal-title":"Blood"},{"issue":"14","key":"832_CR40","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","volume":"118","author":"JW Rowley","year":"2011","unstructured":"Rowley JW, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118(14):e101\u201311.","journal-title":"Blood"},{"issue":"11","key":"832_CR41","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1182\/blood-2015-08-663146","volume":"127","author":"KR Machlus","year":"2016","unstructured":"Machlus KR, et al. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation. Blood. 2016;127(11):1468\u201380.","journal-title":"Blood"},{"issue":"1","key":"832_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-021-00741-7","volume":"28","author":"PS Sung","year":"2021","unstructured":"Sung PS, Hsieh SL. C-type lectins and extracellular vesicles in virus-induced NETosis. J Biomed Sci. 2021;28(1):46.","journal-title":"J Biomed Sci"},{"issue":"7880","key":"832_CR43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41586-021-03925-1","volume":"598","author":"FA Lempp","year":"2021","unstructured":"Lempp FA, et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021;598(7880):342\u20137.","journal-title":"Nature"},{"issue":"6","key":"832_CR44","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.immuni.2021.05.006","volume":"54","author":"Q Lu","year":"2021","unstructured":"Lu Q, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54(6):1304-1319 e9.","journal-title":"Immunity"},{"issue":"11","key":"832_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166474","volume":"11","author":"YL Lo","year":"2016","unstructured":"Lo YL, et al. Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex. PLoS ONE. 2016;11(11): e0166474.","journal-title":"PLoS ONE"},{"issue":"5","key":"832_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S1473-3099(20)30158-4","volume":"20","author":"G Yan","year":"2020","unstructured":"Yan G, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020;20(5):536.","journal-title":"Lancet Infect Dis"},{"key":"832_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100434","volume":"24","author":"AV Rapkiewicz","year":"2020","unstructured":"Rapkiewicz AV, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine. 2020;24: 100434.","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-022-00832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-022-00832-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-022-00832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T14:05:24Z","timestamp":1657634724000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-022-00832-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s12929-022-00832-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.01.478701","asserted-by":"object"}]},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted under the Helsinki Declaration of 1975. All patients provided written informed consent before enrollment, and the study was approved by the Research Ethics Committee of Academia Sinica, Taipei (AS-IRB01-20024, AS-IRB01-20025). Statement of animal operation in BSL-3 biosafety animal facility: All mouse works were conducted in accordance with the \u201cGuideline for the Care and Use of Laboratory Animals\u201d as defined by the Council of Agriculture, Taiwan. Mouse work was approved by the Institutional Animal Care and Use Committee of Academia Sinica (protocol ID: 20-05-1471 and 19-07-1330). The Institutional Biosafety Committee of Academia Sinica approved work with infectious SARS-CoV-2 virus strains under BSL3 conditions. All sample processes were conducted according to \u201cInterim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)\u201d recommended by CDC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}